These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34143825)

  • 21. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep sequencing of the vaginal microbiota of women with HIV.
    Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
    PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCR-based identification of eight Lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of South African women at risk of HIV and BV.
    Dols JA; Reid G; Kort R; Schuren FH; Tempelman H; Bontekoe TR; Korporaal H; Van der Veer EM; Smit PW; Boon ME
    Diagn Cytopathol; 2012 Jun; 40(6):472-7. PubMed ID: 22021225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervicovaginal Microbiome Composition Is Associated with Metabolic Profiles in Healthy Pregnancy.
    Oliver A; LaMere B; Weihe C; Wandro S; Lindsay KL; Wadhwa PD; Mills DA; Pride DT; Fiehn O; Northen T; de Raad M; Li H; Martiny JBH; Lynch S; Whiteson K
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
    Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
    mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women.
    Xu X; Zhang Y; Yu L; Shi X; Min M; Xiong L; Pan J; Liu P; Wu G; Gao G
    Sci Rep; 2022 Apr; 12(1):6609. PubMed ID: 35459771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
    Kaelin EA; Skidmore PT; Łaniewski P; Holland LA; Chase DM; Herbst-Kralovetz MM; Lim ES
    mSystems; 2022 Apr; 7(2):e0006422. PubMed ID: 35343798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women.
    Tamrakar R; Yamada T; Furuta I; Cho K; Morikawa M; Yamada H; Sakuragi N; Minakami H
    BMC Infect Dis; 2007 Nov; 7():128. PubMed ID: 17986357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria.
    Srinivasan S; Hoffman NG; Morgan MT; Matsen FA; Fiedler TL; Hall RW; Ross FJ; McCoy CO; Bumgarner R; Marrazzo JM; Fredricks DN
    PLoS One; 2012; 7(6):e37818. PubMed ID: 22719852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies.
    Molina MA; Coenen BA; Leenders WPJ; Andralojc KM; Huynen MA; Melchers WJG
    mBio; 2022 Oct; 13(5):e0161922. PubMed ID: 35980030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.
    Abdelmaksoud AA; Koparde VN; Sheth NU; Serrano MG; Glascock AL; Fettweis JM; Strauss JF; Buck GA; Jefferson KK
    Microbiology (Reading); 2016 Mar; 162(3):466-475. PubMed ID: 26747455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis.
    Yan DH; Lü Z; Su JR
    Chin Med J (Engl); 2009 Nov; 122(22):2748-51. PubMed ID: 19951608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervicovaginal microbiota, women's health, and reproductive outcomes.
    Kroon SJ; Ravel J; Huston WM
    Fertil Steril; 2018 Aug; 110(3):327-336. PubMed ID: 30098679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiologic Evidence on the Role of Lactobacillus iners in Sexually Transmitted Infections and Bacterial Vaginosis: A Series of Systematic Reviews and Meta-Analyses.
    Carter KA; Fischer MD; Petrova MI; Balkus JE
    Sex Transm Dis; 2023 Apr; 50(4):224-235. PubMed ID: 36729966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.
    Kero K; Rautava J; Syrjänen K; Grenman S; Syrjänen S
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2215-2219. PubMed ID: 28681204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation.
    Bloom SM; Mafunda NA; Woolston BM; Hayward MR; Frempong JF; Abai AB; Xu J; Mitchell AJ; Westergaard X; Hussain FA; Xulu N; Dong M; Dong KL; Gumbi T; Ceasar FX; Rice JK; Choksi N; Ismail N; Ndung'u T; Ghebremichael MS; Relman DA; Balskus EP; Mitchell CM; Kwon DS
    Nat Microbiol; 2022 Mar; 7(3):434-450. PubMed ID: 35241796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study.
    Molina MA; Leenders WPJ; Huynen MA; Melchers WJG; Andralojc KM
    BMC Infect Dis; 2024 Jun; 24(1):552. PubMed ID: 38831406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.
    Lambert JA; John S; Sobel JD; Akins RA
    PLoS One; 2013; 8(12):e82599. PubMed ID: 24376552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.